These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 30766532)

  • 1. Immunomodulatory Effects of Flavonoids: Possible Induction of T CD4+ Regulatory Cells Through Suppression of mTOR Pathway Signaling Activity.
    Hosseinzade A; Sadeghi O; Naghdipour Biregani A; Soukhtehzari S; Brandt GS; Esmaillzadeh A
    Front Immunol; 2019; 10():51. PubMed ID: 30766532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promotion of regulatory T cell induction by immunomodulatory herbal medicine licorice and its two constituents.
    Guo A; He D; Xu HB; Geng CA; Zhao J
    Sci Rep; 2015 Sep; 5():14046. PubMed ID: 26370586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel mTORC1-Dependent, Akt-Independent Pathway Differentiates the Gut Tropism of Regulatory and Conventional CD4 T Cells.
    Chen LC; Nicholson YT; Rosborough BR; Thomson AW; Raimondi G
    J Immunol; 2016 Aug; 197(4):1137-47. PubMed ID: 27402696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silymarin inhibits cell cycle progression and mTOR activity in activated human T cells: therapeutic implications for autoimmune diseases.
    Gharagozloo M; Javid EN; Rezaei A; Mousavizadeh K
    Basic Clin Pharmacol Toxicol; 2013 Apr; 112(4):251-6. PubMed ID: 23121838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia.
    Alameen AA; Simioni C; Martelli AM; Zauli G; Ultimo S; McCubrey JA; Gonelli A; Marisi G; Ulivi P; Capitani S; Neri LM
    Oncotarget; 2016 Aug; 7(34):55690-55703. PubMed ID: 27494886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of PI3K/Akt/mTOR signaling pathway triggered by PTEN downregulation in the pathogenesis of Crohn's disease.
    Long SH; He Y; Chen MH; Cao K; Chen YJ; Chen BL; Mao R; Zhang SH; Zhu ZH; Zeng ZR; Hu PJ
    J Dig Dis; 2013 Dec; 14(12):662-9. PubMed ID: 23962154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Regulatory Effects of mTOR Complexes in the Differentiation and Function of CD4
    Wang P; Zhang Q; Tan L; Xu Y; Xie X; Zhao Y
    J Immunol Res; 2020; 2020():3406032. PubMed ID: 32377533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cells potently purge latent HIV-1 beyond TCR-stimulation, activating the PI3K-Akt-mTOR pathway.
    van Montfort T; van der Sluis R; Darcis G; Beaty D; Groen K; Pasternak AO; Pollakis G; Vink M; Westerhout EM; Hamdi M; Bakker M; van der Putten B; Jurriaans S; Prins JH; Jeeninga R; Thomas AAM; Speijer D; Berkhout B
    EBioMedicine; 2019 Apr; 42():97-108. PubMed ID: 30824386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flavonoids as Th1/Th2 cytokines immunomodulators: A systematic review of studies on animal models.
    Gandhi GR; Neta MTSL; Sathiyabama RG; Quintans JSS; de Oliveira E Silva AM; Araújo AAS; Narain N; Júnior LJQ; Gurgel RQ
    Phytomedicine; 2018 May; 44():74-84. PubMed ID: 29895495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Akt/mTOR signaling by the dietary flavonoid fisetin.
    Syed DN; Adhami VM; Khan MI; Mukhtar H
    Anticancer Agents Med Chem; 2013 Sep; 13(7):995-1001. PubMed ID: 23293889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of different components from Ophiopogon japonicus on autophagy in human lung adenocarcinoma A549Cells through PI3K/Akt/mTOR signaling pathway.
    Chen J; Yuan J; Zhou L; Zhu M; Shi Z; Song J; Xu Q; Yin G; Lv Y; Luo Y; Jia X; Feng L
    Biomed Pharmacother; 2017 Mar; 87():118-126. PubMed ID: 28049093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of DJ-1/PARK7 on development of natural and induced regulatory T cells.
    Singh Y; Chen H; Zhou Y; Föller M; Mak TW; Salker MS; Lang F
    Sci Rep; 2015 Dec; 5():17723. PubMed ID: 26634899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the PI3K-Akt-mTOR signaling pathway in T lymphocytes in patients with active tuberculosis.
    Zhang X; Huang T; Wu Y; Peng W; Xie H; Pan M; Zhou H; Cai B; Wu Y
    Int J Infect Dis; 2017 Jun; 59():110-117. PubMed ID: 28416440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual Inhibition of PI3K/Akt and mTOR by the Dietary Antioxidant, Delphinidin, Ameliorates Psoriatic Features In Vitro and in an Imiquimod-Induced Psoriasis-Like Disease in Mice.
    Chamcheu JC; Adhami VM; Esnault S; Sechi M; Siddiqui IA; Satyshur KA; Syed DN; Dodwad SM; Chaves-Rodriquez MI; Longley BJ; Wood GS; Mukhtar H
    Antioxid Redox Signal; 2017 Jan; 26(2):49-69. PubMed ID: 27393705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTOR regulates T-cell differentiation and activation in immunity and autoimmunity.
    Bi Y; Liu G; Yang R
    Crit Rev Eukaryot Gene Expr; 2011; 21(4):313-22. PubMed ID: 22181701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTOR signaling in the differentiation and function of regulatory and effector T cells.
    Zeng H; Chi H
    Curr Opin Immunol; 2017 Jun; 46():103-111. PubMed ID: 28535458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baicalin induces apoptosis in leukemia HL-60/ADR cells via possible down-regulation of the PI3K/Akt signaling pathway.
    Zheng J; Hu JD; Chen YY; Chen BY; Huang Y; Zheng ZH; Liu TB
    Asian Pac J Cancer Prev; 2012; 13(4):1119-24. PubMed ID: 22799292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of miR-633 activated AKT/mTOR pathway by targeting AKT1 in lupus CD4
    Chen S; Wang Y; Qin H; Lin J; Xie L; Chen S; Liang J; Xu J
    Lupus; 2019 Apr; 28(4):510-519. PubMed ID: 30760089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oscillatory mTOR inhibition and Treg increase in kidney transplantation.
    Sabbatini M; Ruggiero G; Palatucci AT; Rubino V; Federico S; Giovazzino A; Apicella L; Santopaolo M; Matarese G; Galgani M; Terrazzano G
    Clin Exp Immunol; 2015 Nov; 182(2):230-40. PubMed ID: 26077103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed Death-1 Inhibition of Phosphatidylinositol 3-Kinase/AKT/Mechanistic Target of Rapamycin Signaling Impairs Sarcoidosis CD4
    Celada LJ; Rotsinger JE; Young A; Shaginurova G; Shelton D; Hawkins C; Drake WP
    Am J Respir Cell Mol Biol; 2017 Jan; 56(1):74-82. PubMed ID: 27564547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.